Prosecution Insights
Last updated: November 10, 2026
Application No. 19/104,316

METHOD OF SENSING AN ANALYTE USING MACHINE LEARNING

Non-Final OA §102§103
Filed
Feb 17, 2025
Priority
Aug 18, 2022 — provisional 63/399,156 +1 more
Examiner
GAMBLE JR, RANDALL LEE
Art Unit
1795
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Eye3Concepts Inc.
OA Round
1 (Non-Final)
51%
Grant Probability
Moderate
1-2
OA Rounds
1y 6m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants 51% of resolved cases
51%
Career Allowance Rate
21 granted / 41 resolved
-13.8% vs TC avg
Strong +21% interview lift
Without
With
+21.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
28 currently pending
Career history
79
Total Applications
across all art units

Statute-Specific Performance

§101
6.2%
-33.8% vs TC avg
§103
57.5%
+17.5% vs TC avg
§102
8.4%
-31.6% vs TC avg
§112
27.5%
-12.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 41 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Information Disclosure Statement The information disclosure statement (IDS) submitted on 02/17/2025 and 11/21/2025 have been considered by the examiner. Claim Objections Claims 1, 10, and 21 are objected to because of the following informalities: Claim 1, please amend “a sensing electrode of the sensor” to “a sensing electrode of the electrochemical sensor”. Claim 10, please amend “wherein the target range of electric potential is from 0 to 5 V” to “wherein the target range of electric potentials is from 0 to 5 V”. Claim 21, please amend “soft Regression, decision Tree” to “soft [[R]]regression, decision [[T]]tree”. Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-7, 11, 14-17, 19-22, and 24 are rejected under 35 U.S.C. 102(a)(1) and 35 U.S.C. 102(a)(2) as being anticipated by Ben-Yoav (US 2020/0138344A1). Regarding Claim 1, Ben-Yoav teaches a method of sensing an analyte (method of sensing an analyte including dopamine and/or norepinephrine [para. 0019]) in a sample (biofluid sample [para. 0019]) by electrochemical detection (analysis of biofluid samples using voltammetry [para. 0019]), the method comprising: receiving the sample on a sample receiving region (section of electrodes, including working electrode 5, serves as sample receiving region [para. 0020]; illustrated in Fig. 2) of an electrochemical sensor (working electrodes are immersed in liquid sample [para. 0020]), the sample receiving region being in fluid communication with a sensing electrode of the sensor (working electrodes are immersed in liquid sample [para. 0020]; working electrodes 5 serve as sensing electrodes [para. 0020]); applying an electric potential scan in a target range of electric potentials to the sensing electrode (as illustrated in Figures 4A and 4B, voltage is varied from -0.1 to 0.4 V) to induce an electrochemical reaction with the analyte (a voltammetry involves an electroactive species that undergoes oxidation and/or reduction [para. 0003]; electrochemical technique that employed can be, for example, is differential pulse voltammetry [para. 0101]); measuring an electrical signal from the sensing electrode while the electric potential is applied (as illustrated in Figures 4A and 4B, current of the working electrode is measured); inputting the electrical signal into a processing device (processor 11 [para. 0053] analyzes a data set of electrochemical signals [para. 0053]) having at least one machine learning algorithm operating therein (data sets of electrochemical signals are analyzed by multivariate methods such as a supervised machine learning model [para. 0053]); and executing, by the processing device, the at least one machine learning algorithm to determine from the electrical signal a presence or an absence of the analyte in the sample (machine learning model is used to detect dopamine in the presence of other analytes including uric acid and norepinephrine [paras. 0123-0147]). Regarding Claim 2, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the sensing electrode has a plurality of sensor analytes associated therewith (sensing analytes can be dopamine and norepinephrine [para. 0005]). Regarding Claim 3, Ben-Yoav teaches a method of claim 1. Ben-Yoav teaches wherein the electrochemical reaction is an oxidation or a reduction (differential pulse voltammetry is used, a voltammetry involves an electroactive species that undergoes oxidation and/or reduction [para. 0003]). Regarding Claim 4, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the electrical signal is an electric current (as illustrated in Figures 4A and 4B, current is measured as a function of voltage). Regarding Claim 5, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the sample comprises a body fluid (biofluid can be urine, blood, and saliva [para. 0019]). Regarding Claim 6, Ben-Yoav teaches the method of claim 5. Ben-Yoav teaches wherein the sample comprises blood, sputum, or urine (biofluid may be blood, saliva, or urine [para. 0019]). Regarding Claim 7, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the electric potential is applied using a voltametric technique selected from differential pulse voltammetry (voltammetry may be differential pulse voltammetry [para. 0019]). Regarding Claim 11, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm is executed by the processing device to determine the presence or the absence of the analyte in a sample comprising determining a single value of a concentration of the analyte in the sample (after collecting test data and using machine learning, such as an ANN algorithm, the concentration of analyte is quantified [para. 0056]). Regarding Claim 14, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm is configured to decrease noise percent in the electrical signal for determining the presence or the absence of the analyte in the sample (a varied filter order is used depending on the noise level [para. 0072]), the noise resulting from analog compound interference in the sample (noise component can be a different component, such as uric acid [para. 0134]). Regarding Claim 15, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm is trained with at least one statistical feature of the electrical signal (features of the voltammogram were obtained for each data set [para. 0133]), the at least one statistical feature comprising at least one of a maximum (feature may be a peak potential [para. 0133]). Regarding Claim 16, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm is trained with an entirety of the electrical signal (as discussed in [paras. 0124-0130], a set consisting of 216 mixtures of dopamine and norepinephrine voltammograms were used). Regarding Claim 17, Ben-Yoav teaches the method of claim 16. Ben-Yoav teaches further comprising, prior to executing the at least one machine learning algorithm, reducing a dimensionality of the electrical signal using principal component analysis (PCA) (raw test data collected by the electrochemical sensor undergoes preprocessing with the aid of known techniques, such as principal component analysis [para. 0055]). Regarding Claim 19, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm is a supervised machine learning algorithm or an unsupervised machine learning algorithm (a supervised or unsupervised machine learning algorithm [Claim 15]). Regarding Claim 20, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm is configured to perform at least one of a regression analysis (a regression model [para. 0053]) and a classification task to determine the concentration of the analyte from the electrical signal (complete solution matrix consists of all possible binary combinations of concentrations [para. 0105]; note that sorting data into binary combinations is a way to classify the data). Regarding Claim 21, Ben-Yoav teaches the method of claim 20. Ben-Yoav teaches wherein the at least one machine learning algorithm is configured to perform the classification task using an artificial neural network (ANN) (artificial neural network [para. 0053]). Regarding Claim 22, Ben-Yoav teaches the method of claim 21. Ben-Yoav teaches wherein the at least one machine learning algorithm is configured to perform the regression analysis using linear regression (partial least squares regression is used, which is a linear regression technique [para. 0054]). Regarding Claim 24, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the analyte is a metabolite (metabolite is a neurotransmitter including dopamine and norepinephrine [para. 0005]). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 10 is rejected under 35 U.S.C. 103 as being unpatentable over Ben-Yoav. Regarding Claim 10, Ben-Yoav teaches the method of claim 1. Ben-Yoav is silent on wherein the target range of electric potential is from 0 to 5 V. However, Ben-Yoav teaches wherein the target range of electric potential is from voltage is varied from -0.1 to 0.4 V (as illustrated in Figure 4A and 4B, voltage is varied from -0.1 to 0.4 V). It would be obvious to one of ordinary skill in the art prior to the effective filing date of the claimed invention to use a target range of electric potential within the disclosed range, as taught by Ben-Yoav, including those amounts that overlap with the claimed range, since one of ordinary skill in the art would reasonably expect any value within the target range to be suitable given that Ben-Yoav specially teaches using differential pulse voltammetry to apply a voltage sweep for detection of analytes (Ben-Yoav, Figure 4A and 4B). It has been held that obviousness exists where the claimed ranges overlap or lie inside ranges disclosed by the prior art. See MPEP 2144.05 (I). Claim 13 is rejected under 35 U.S.C. 103 as being unpatentable over Ben-Yoav in view of Mirza (Closed-Loop Implantable Therapeutic Neuromodulation Systems Based on Neurochemical Monitoring. Frontiers in Neuroscience 2019; 808(13), 1-18). Regarding Claim 13, Ben-Yoav teaches the method of claim 1. Ben-Yoav is silent on wherein the at least one machine learning algorithm is executed by the processing device to determine the presence or the absence of the analyte in the sample comprising determining whether the concentration of the sample is above or below a predetermined concentration threshold. Mirza teaches neuromodulation for nuerotransmitters including dopamine and serotonin (abstract), and teaches wherein the at least one machine learning algorithm is executed by the processing device to determine the presence or the absence of the analyte in the sample comprising determining whether the concentration of the sample is above or below a predetermined concentration threshold (decision making can be used based on a threshold of analyte concentration [col. 1 second para. page 11]). It would be obvious to one of ordinary skill in the art prior to the effective filing date of the claimed invention to modify the at least one machine learning algorithm of Ben-Yoav to be is executed by the processing device to determine the presence or the absence of the analyte in the sample comprising determining whether the concentration of the sample is above or below a predetermined concentration threshold, as taught by Mirza, as detecting a certain threshold for presence of an analyte allows for a decision on how much to stimulate (Mirza, [Figure 3]). Claim 23 is rejected under 35 U.S.C. 103 as being unpatentable over Ben-Yoav in view of Patarnello (Phasic dopamine release identification using ensemble of AlexNet. ArXiV: Computer Science – Computer Vision and Pattern Recognition. 2020, 1-14). Regarding Claim 23, Ben-Yoav teaches the method of claim 1. Ben-Yoav teaches wherein the at least one machine learning algorithm comprises a plurality of different machine learning algorithms combined into an ensemble machine learning model. Patarnello teaches identifying dopamine using ensemble of AlexNet (abstract), and teaches wherein the at least one machine learning algorithm comprises a plurality of different machine learning algorithms (ensemble may consist of multiple AlexNet networks and YOLOv2 detectors [last para. page 10]) combined into an ensemble machine learning model (machine learning is used to train model by various dataset variations using an ensemble of machine learning tools for classifying (see Figure 5 on page 11 and Table 6 on page 12). Ben-Yoav and Patarnello are considered analogous art to the claimed invention because they are in the same field of neurotransmitter detection using machine learning. It would be obvious to one of ordinary skill in the art prior to the effective filing date of the claimed invention to modify the at least one machine learning algorithm of Ben-Yoav to be a plurality of different machine learning algorithms combined into an ensemble machine learning model, as taught by Patarnello, as ensemble machine learning models can successfully perform tasks and outperform other machine learning methods in accuracy and simplicity (Patarnello, [Abstract]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to RANDALL LEE GAMBLE JR whose telephone number is (703)756-5492. The examiner can normally be reached Mon - Fri 10:00-6:00 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Luan Van can be reached at (571) 272-8521. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /R.L.G./Examiner, Art Unit 1795 /SHIZHI QIAN/Primary Examiner, Art Unit 1795
Read full office action

Prosecution Timeline

Feb 17, 2025
Application Filed
Aug 20, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12782316
pH SENSOR WITH SECONDARY REFERENCE ELECTRODE
4y 7m to grant Granted Nov 03, 2026
Patent 12779459
MICROFLUIDIC DEVICE
4y 1m to grant Granted Nov 03, 2026
Patent 12746545
PATTERN ELECTRODE STRUCTURE FOR ELECTROWETTING APPARATUS
4y 4m to grant Granted Sep 29, 2026
Patent 12692608
CARBON FREE GAS DIFFUSION ELECTRODE
3y 6m to grant Granted Jul 28, 2026
Patent 12673333
METHODS OF PENNING MICRO-OBJECTS USING POSITIVE DIELECTROPHORESIS
4y 0m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
51%
Grant Probability
73%
With Interview (+21.4%)
3y 3m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 41 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month